Sebert, M., Santini, V., Platzbecker, U., Valcárcel, D., Borate, U., Yuan, W., Kapsalis, S., Simonot, L., Panzica, M., Patel, P., Garcia-Manero, G. (2025). PyramIDH: A phase 3 study of ivosidenib monotherapy or azacitidine monotherapy in patients with mutant isocitrate dehydrogenase 1 myelodysplastic syndromes who have not received prior hypomethylating agent therapy. Blood. https://doi.org/10.1182/blood-2025-8254